Through a combination of knockdown and rescue strategies in aggressive mesenchymal-like breast cancer cells, we demonstrate that ectopic CCN6 overexpression or treatment with recombinant CCN6 downregulates Slug and is sufficient to reduce Notch1 signaling and transcriptional activity, reverse EMT, and reduce the number of TICs. This evidence concerns the gene CCN6 and breast cancer.